Australia markets closed

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.32000.0000 (0.00%)
At close: 04:00PM EDT
1.3100 -0.01 (-0.76%)
After hours: 07:17PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
35,277
88,227
25,218
198,955
Other short-term investments
268,339
416,750
708,737
862,941
Total cash
303,616
504,977
733,955
1,061,896
Net receivables
1,205
5,981
22,492
38,889
Inventory
16,101
19,202
15,801
15,292
Other current assets
-
15,808
23,333
21,928
Total current assets
330,701
545,968
795,581
1,138,005
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
123,761
210,617
325,574
324,626
Accumulated depreciation
-86,898
-124,731
-148,039
-138,488
Net property, plant and equipment
36,863
85,886
177,535
186,138
Equity and other investments
25,825
0
64,828
136,662
Goodwill
0
76,501
76,501
76,501
Other long-term assets
4,644
2,245
2,744
1,461
Total non-current assets
67,332
164,632
321,608
400,762
Total assets
398,033
710,600
1,117,189
1,538,767
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
9,848
12,980
9,747
22,139
Accrued liabilities
16,609
26,975
42,277
65,193
Deferred revenues
-
-
-
91
Total current liabilities
51,269
68,204
85,200
115,779
Non-current liabilities
Deferred revenues
-
-
-
2,464
Other long-term liabilities
117,260
162,929
199,019
209,320
Total non-current liabilities
215,777
275,758
352,481
345,693
Total liabilities
267,046
343,962
437,681
461,472
Stockholders' equity
Common stock
19
19
19
18
Retained earnings
-3,477,249
-3,201,193
-2,832,995
-2,309,158
Accumulated other comprehensive income
80
-6,907
-4,157
-2,295
Total stockholders' equity
130,987
366,638
679,508
1,077,295
Total liabilities and stockholders' equity
398,033
710,600
1,117,189
1,538,767